Description
The global Breast Biopsy Market was calculated at USD 1129 million in 2021 and is estimated to reach USD 1992 million by 2028, growing at a CAGR of 5.6% during the forecast period of 2022 to 2028. The increase in awareness regarding early detection of breast cancer and the improved reimbursement scheme further influence the market growth. Further, the rise in population, surge in healthcare expenditure and rise in endeavors by public organizations towards female health problems thoroughly affect the breast biopsy devices market.
What is Breast Biopsy?
A breast biopsy is a test conducted to extract tissue or fluid from a diseased place of the patient’s body, while the extracted sample is further analyzed to check the presence of breast cancer. There are different types of biopsy methods depending on the product, such as vacuum-assisted biopsy, core needle biopsy, and fine-needle aspiration biopsy, recommended by the doctor based on location and size and different elements of the breast irregularity. The different methods of the biopsy market work fast, and it is easy. As a result, the results are fast and correct.
